Novartis AG
NVSEF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001114448
No open-market purchases or sales by Novartis AG insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $6.28M in total; no superinvestor holds it.
Other share classesNVS
Key figures
- Market capADS ratio not in SEC data
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 2
- 13F valueReported value at the end of Q2 2026
- $6.28M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $54.5B
- +8.4% year over year
- Net income, FY2025
- $14.0B
- +17.0% year over year
- Free cash flow, FY2025
- $17.6B
- +8.3% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.02M
- Shares sold short
- Change
- −657.6K
- −39.3% vs. previous
- Days to cover
- 8.65
- At average daily volume
Superinvestors holding NVSEF, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NVSEF at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Novartis AG insiders from Form 4, newest first.
No open-market purchases or sales by Novartis AG insiders are on file.
Top 10 13F holders, Q2 2026
See all 2 holdersThe largest institutional positions in Novartis AG at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Partners Capital Investment Group, LLP | 24,335 | $3.81M | 0.13% | −3,879−13.7% | Reduced |
| Generali Investments CEE, investicni spolecnost, a.s. | 15,729 | $2.46M | 0.12% | −1,328−7.8% | Reduced |
Holders of 5% or more of NVSEF
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Novartis AG.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.10%145.2M shares | – | Oct 27, 20261 filing | Oct 27, 2026 | SEC |
Politician trades
All politician trades in NVSEF14 members of Congress reported 42 trades in Novartis AG since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 25, 2026 |  Kevin Hern House · OK | Sell | $15K-$50K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Jul 21, 2026 | Alan Armstrong Senate · OK | Buy | $1K-$15K |
| Nov 21, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
| Nov 21, 2025 | Lisa C. McClain House · MI | Buy | $1K-$15K |
House · OK · Sep 25, 2026
Sell$15K-$50K
Senate · OK · Jul 21, 2026
Buy$15K-$50K
Senate · OK · Jul 21, 2026
Buy$1K-$15K
House · MI · Nov 21, 2025
Sell$1K-$15K
House · MI · Nov 21, 2025
Buy$1K-$15K